|
Volumn 41, Issue 2, 2015, Pages 159-160
|
Marked response to 177lu prostate-specific membrane antigen treatment in patient with metastatic prostate cancer
|
Author keywords
177Lu PSMA treatment; 68Ga PSMA PET CT; Prostatic cancer
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
PROSTATE SPECIFIC ANTIGEN;
PROSTATE SPECIFIC MEMBRANE ANTIGEN GA 68;
PROSTATE SPECIFIC MEMBRANE ANTIGEN LU 177;
RADIOPHARMACEUTICAL AGENT;
UNCLASSIFIED DRUG;
EDETIC ACID;
GLU-NH-CO-NH-LYS-(AHX)-((68)GA(HBED-CC));
LUTETIUM;
OLIGOPEPTIDE;
ADULT;
ARTICLE;
BONE METASTASIS;
CANCER HORMONE THERAPY;
CANCER PATIENT;
CANCER SCINTISCANNING;
CANCER SURGERY;
CASE REPORT;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMUR;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HUMERUS;
LYMPH NODE METASTASIS;
MALE;
MEDIASTINUM LYMPH NODE;
MIDDLE AGED;
MULTIPLE CYCLE TREATMENT;
PELVIC GIRDLE;
PET-CT SCANNER;
PROSTATE CANCER;
PROSTATECTOMY;
RIB;
SCAPULA;
SCINTILLATION CAMERA;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SKULL;
SPINE;
STOMACH PAIN;
THORACIC VERTEBRA;
TREATMENT RESPONSE;
VOMITING;
WHOLE BODY SCINTISCANNING;
ANALOGS AND DERIVATIVES;
COMPUTER ASSISTED TOMOGRAPHY;
METASTASIS;
MULTIMODAL IMAGING;
PATHOLOGY;
POSITRON EMISSION TOMOGRAPHY;
PROSTATIC NEOPLASMS;
SCINTISCANNING;
EDETIC ACID;
HUMANS;
LUTETIUM;
MALE;
MIDDLE AGED;
MULTIMODAL IMAGING;
NEOPLASM METASTASIS;
OLIGOPEPTIDES;
POSITRON-EMISSION TOMOGRAPHY;
PROSTATIC NEOPLASMS;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 84945257151
PISSN: 03639762
EISSN: 15360229
Source Type: Journal
DOI: 10.1097/RLU.0000000000001058 Document Type: Article |
Times cited : (8)
|
References (8)
|